Switch theme
Sign up to access all valuation multiples
Previously owned by the Australian government, Medibank is the largest health insurer in Australia. Its two brands, Medibank Private and Ahm, cover around 4 million people. Medibank and Australia's fourth-largest health fund, NIB Holdings, are the only listed health insurers. In addition to private health insurance, the firm provides life, pet, and travel insurance, as well as health insurance for overseas students and temporary overseas workers. The Medibank Health division provides healthcare services to businesses, governments, and communities across Australia and New Zealand.
1997
3.6K+
LTM Revenue $5.5B
LTM EBITDA $507M
$8.3B
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
Medibank has a last 12-month revenue (LTM) of $5.5B and a last 12-month EBITDA of $507M.
In the most recent fiscal year, Medibank achieved revenue of $5.2B and an EBITDA of n/a.
Medibank expects next 12-month revenue of XXX and NTM EBITDA of XXX
See Medibank valuation multiples based on analyst estimates| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue | $5.5B | XXX | $5.2B | XXX | XXX | XXX |
| Gross Profit | $543M | XXX | n/a | XXX | XXX | XXX |
| Gross Margin | 10% | XXX | n/a | XXX | XXX | XXX |
| EBITDA | $507M | XXX | n/a | XXX | XXX | XXX |
| EBITDA Margin | 9% | XXX | n/a | XXX | XXX | XXX |
| EBIT | $489M | XXX | n/a | XXX | XXX | XXX |
| EBIT Margin | 9% | XXX | n/a | XXX | XXX | XXX |
| Net Profit | $384M | XXX | $316M | XXX | XXX | XXX |
| Net Margin | 7% | XXX | 6% | XXX | XXX | XXX |
| Net Debt | XXX | XXX | n/a | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of May 30, 2025, Medibank's stock price is AUD 5 (or $3).
Medibank has current market cap of AUD 13.1B (or $8.4B), and EV of AUD 12.9B (or $8.3B).
See Medibank trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $8.3B | $8.4B | XXX | XXX | XXX | XXX | $0.14 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Start Free TrialAs of May 30, 2025, Medibank has market cap of $8.4B and EV of $8.3B.
Medibank's trades at 1.5x EV/Revenue multiple, and n/a EV/EBITDA.
Equity research analysts estimate Medibank's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Medibank has a P/E ratio of 22.0x.
See valuation multiples for Medibank and 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $8.4B | XXX | $8.4B | XXX | XXX | XXX |
| EV (current) | $8.3B | XXX | $8.3B | XXX | XXX | XXX |
| EV/Revenue | 1.5x | XXX | 1.5x | XXX | XXX | XXX |
| EV/EBITDA | 16.3x | XXX | n/a | XXX | XXX | XXX |
| EV/EBIT | 16.9x | XXX | n/a | XXX | XXX | XXX |
| EV/Gross Profit | 15.2x | XXX | n/a | XXX | XXX | XXX |
| P/E | 22.0x | XXX | 23.9x | XXX | XXX | XXX |
| EV/FCF | 19.5x | XXX | 17.7x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Start Free TrialMedibank's last 12 month revenue growth is 5%
Medibank's revenue per employee in the last FY averaged $1.4M, while opex per employee averaged n/a for the same period.
Medibank's rule of 40 is unknown (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Medibank's rule of X is 21% (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
See operational valuation multiples for Medibank and other 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 5% | XXX | 5% | XXX | XXX | XXX |
| EBITDA Margin | 9% | XXX | n/a | XXX | XXX | XXX |
| EBITDA Growth | 7% | XXX | n/a | XXX | XXX | XXX |
| Rule of 40 | n/a | XXX | n/a | XXX | XXX | XXX |
| Bessemer Rule of X | XXX | XXX | 21% | XXX | XXX | XXX |
| Revenue per Employee | XXX | XXX | $1.4M | XXX | XXX | XXX |
| Opex per Employee | XXX | XXX | n/a | XXX | XXX | XXX |
| S&M Expenses to Revenue | XXX | XXX | 2% | XXX | XXX | XXX |
| G&A Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| R&D Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| Opex to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| ADNIC | XXX | XXX | XXX | XXX | XXX | XXX |
| Aegon | XXX | XXX | XXX | XXX | XXX | XXX |
| ASR Nederland | XXX | XXX | XXX | XXX | XXX | XXX |
| NN Group | XXX | XXX | XXX | XXX | XXX | XXX |
| Challenger | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Medibank acquired XXX companies to date.
Last acquisition by Medibank was XXXXXXXX, XXXXX XXXXX XXXXXX . Medibank acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Start Free Trial| When was Medibank founded? | Medibank was founded in 1997. |
| Where is Medibank headquartered? | Medibank is headquartered in Australia. |
| How many employees does Medibank have? | As of today, Medibank has 3.6K+ employees. |
| Who is the CEO of Medibank? | Medibank's CEO is Mr. David Koczkar, B.Com. |
| Is Medibank publicy listed? | Yes, Medibank is a public company listed on ASX. |
| What is the stock symbol of Medibank? | Medibank trades under MPL ticker. |
| When did Medibank go public? | Medibank went public in 2014. |
| Who are competitors of Medibank? | Similar companies to Medibank include e.g. ADNIC, Aegon, ASR Nederland, NN Group. |
| What is the current market cap of Medibank? | Medibank's current market cap is $8.4B |
| What is the current revenue of Medibank? | Medibank's last 12 months revenue is $5.5B. |
| What is the current revenue growth of Medibank? | Medibank revenue growth (NTM/LTM) is 5%. |
| What is the current EV/Revenue multiple of Medibank? | Current revenue multiple of Medibank is 1.5x. |
| Is Medibank profitable? | Yes, Medibank is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of Medibank? | Medibank's last 12 months EBITDA is $507M. |
| What is Medibank's EBITDA margin? | Medibank's last 12 months EBITDA margin is 9%. |
| What is the current EV/EBITDA multiple of Medibank? | Current EBITDA multiple of Medibank is 16.3x. |
| What is the current FCF of Medibank? | Medibank's last 12 months FCF is $424M. |
| What is Medibank's FCF margin? | Medibank's last 12 months FCF margin is 8%. |
| What is the current EV/FCF multiple of Medibank? | Current FCF multiple of Medibank is 19.5x. |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
